Biochemistry & Molecular Biology Faculty
Faculty Departments
- Biochemistry and Molecular Biology
- Cellular and Integrative Physiology
- College of Dentistry, College of Pharmacy
- College of Public Health
- Eppley Institute
- Genetics Cell Biology and Anatomy
- Internal Medicine
- Munroe-Meyer Institute
- Obstetrics and Gynecology
- Pathology, Microbiology, and Immunology
- Pharmacology and Experimental Neuroscience
- Radiation Oncology
Faculty
Maher Abdalla, PhD Research focus: Reactive Oxygen Species (ROS), Heme Oxygenase-1 (HO-1) and immune cells in pancreatic ductal adenocarcinoma (PDAC) and prostate cancer. |
|
Yazen Alnouti, PhD Research focus: Drug metabolism and pharmacokinetics (DMPK), with a focus on the application of Bioanalytical Chemistry, in vitro and in vivo animal models to support ADMET (absorption, distribution, metabolism, excretion and toxicity) and pharmacokinetic (PK) studies; Biomarkers for hepato-biliary diseases based on bile acid metabolism by sulfation. |
|
Hamid Band, MD, PhD Research focus: Regulation of receptor signaling by endocytic traffic; Cbl-family and CHIP ubiquitin ligases; EHD-family endocytic recycling regulators; mouse genetic models; cancer biology;and stem cell biology. |
|
Vimla Band, PhD Research focus: Delineate molecular mechanisms of early steps in transformation of mammary epithelial cells with the goal of identifying novel molecular diagnostic/prognostic markers and potential therapy targets of breast cancers. |
|
Surinder K. Batra, PhD Research focus: Structure/function analysis of tumor-associated genes; cancer diagnostics, cancer vaccines; monoclonal antibodies, genetic engineering of antibodies. |
|
Robert Bennett, PhD Research focus: Antifibrotic effects of the hormone relaxin and related peptides; expression and signaling of relaxin receptors; internalization and degradation of relaxin, insulin and related hormones; the role of relaxin in adipose function. |
|
Raymond Bergan, MD Research focus: Understanding how cancer cells regulate transformation to a high motility metastatic phenotype, and how that process can be therapeutically modulated. |
|
Kishor K. Bhakat, PhD Research focus: Understanding the molecular mechanisms and alter the damage repair pathways and gene expression in tumor cells to promote therapy resistance and tumor recurrence, and develop second line of interventions to prevent tumor recurrence and metastasis. |
|
Piero Bianco, PhD Research focus: Stalled DNA replication fork rescue to maintain genome stability |
|
Jennifer Black, PhD Research focus: Colon cancer; endometrial cancer; pancreatic cancer; cell signaling (kinases and phosphatases) cell cycle regulation; control of protein translation in cancer; protein kinase C; PP2A. |
|
Gloria Borgstahl, PhD Research focus: Structural biology, structure-based drug design, superoxide dismutase and double-strand DNA repair by homologous recombination. |
|
Sandipan Brahma, PhD Research focus: Mechanisms regulating chromatin structure, how cells use these mechanisms to establish and maintain gene expression programs, and the implications of these mechanisms for human health. |
|
Shilpa Buch, PhD Research focus: Therapeutic strategies that may enhance neural function and survival in NeuroAIDS, with possible implications in other neurodegenerative diseases. |
|
Siddappa Byrareddy, PhD Research focus: Understanding and developing therapeutics for emerging/re-emerging viruses, focusing on HIV, Zika and SARS-CoV-2. |
|
Steve Caplan, PhD Research focus: Study of endocytic membrane trafficking, receptor recycling, vesicular transport, endosomes, mechanisms of mitochondrial fission/fusion, ciliogenesis and mechanisms by which primary cilia are generated, and centrosome biology. |
|
Rey Carabeo, PhD Research focus: Cytoskeletal dynamics and mechanostransduction in Chlamydia invasion and pathogen modulation of host epithelial cell-extracellular matrix interaction; Transcriptomic studies of Chlamydia stress adaption. |
|
Carol A. Casey, PhD Research focus: Biochemistry of alcoholism and digestive system diseases. |
|
Kishore Challagundla, PhD Research focus: Role of extra cellular vesicles (EV's) and the non-coding RNAs in affecting immunotherapy response and escaping immune surveillance in pediatric cancers, in particular neuroblstoma and acute myeloid leukemia. |
|
Nagendra Chaturvedi, PhD Research focus: Medulloblastoma; Neuroblastoma; Oncogenic signaling pathways; Small molecule therapeutics; Development of clincally relevant animal models; Stem cell biology; Epigenetic regulation of peadiatric cancers. |
|
Sujata Chaudhari, PhD Research focus: rthropod physiology and bacterial pathogenesis; study of tick vector physiology with focus on cuticle development and pathogen transmission; chitin metabolism in arthropods using Tribolium castaneum as a genetic model system; Staphylococcal metabolism and stress response. |
|
Pi-Wan Cheng, PhD Research focus: Study of the mechanism of altered glycosylation in human disease. |
|
Vinai Chittezham Thomas, PhD Research focus: Staphylococcal physiology and metabolism; staphylococcus stress response. |
|
Suyong Choi, PhD Research focus: Phosphoinositide signaling pathways in cancer and immunology. |
|
Martin Conda-Sheridan, PhD Research focus: Design of complex multifunctional biomaterials and bioactive small molecules for medicinal applications. |
|
John S. Davis, PhD Research focus: Women's health; Reproductive endocrinology and cancer; Mechanisms of hormone action. |
|
Rebecca Oberley-Deegan, PhD Research focus: Role of free radicals signaling to transform fibroblasts and inflammatory cells in normal tissue, which results in damage to these tissues; understanding the mechanisms by which ROS promote radiation induced fibrosis and prostate cancer progression. |
|
Paul Denton, PhD Research focus: Improving immunotherapies to treat malignancies. |
|
Punita Dhawan, PhD Research focus: Development of novel therapeutic targets for Gastrointestinal Cancer progression and chemoresistance; Role of signaling pathways and cancer stem cells involved in this process using cell culture, mouse and organoid models. |
|
Jixin Dong, PhD Research focus: Hippo signaling and cancer; Chemotherapeutic drug resistance. |
|
Andrew Dudley, PhD Research focus: Mechanisms that regulate the development and homeostasis of musculoskeletal tissue using methods from embryology, molecular biology, cell biology, genetics and tissue engineering, with the goal of generating novel therapies for regenerative medicine. |
|
Anna Dunaevsky, PhD Research focus: Synaptic plasticity and neuron-glia interactions in neurocognitive disorders. |
|
Dalia Elgamal, PhD Research focus: Pathogenesis of B-cell malignancies, including immunosuppressive microenvironmental interactions and the gut microbiome, and evaluating novel anti-tumor therapeutics strategies. |
|
Howard Fox, MD, PhD Research focus: Neurodegeneration, viral infections, single cell analyses of the brain, translational research in neuroscience. |
|
Jered Garrison, PhD Research focus: Targeted molecular imaging and radiotherapeutic agent design; development of cancer-specific prodrugs; polymer based drug delivery systems. |
|
Howard E. Gendelman, MD Research focus: Development and testing of HIV-1 cure strategies; Basic and clinical studies on novel medicines to treat Parkinson's disease. |
|
Gargi Ghosal, PhD Research focus: Understand the basic science underlying replication stress response in cancer and aging, identify new targets and bio-markers for cancer therapy and facilitate the development of strategies to overcome drug resistance and improve cancer therapies. |
|
Santhi Gorantla, PhD Research focus: Humanized mouse models for HIV brain infection; influence of substance use on brain HIV latency, inflammation and pathogenesis. |
|
Michael A. (Tony) Hollingsworth, PhD Research focus: Basic and transactional research in pancreatic cancer, including investigation of the biology of tumor progress, discovery and validation of biomarkers of early detection and disease progression, development and testing of novel therapeutics, including targeted therapies and immunotherapies. |
|
Sarah Holstein, MD, PhD Research focus: Development of novel agents for the treatment of multiple myeloma and pancreatic cancer, with a particular focus on Rab inhibitors of the isoprenoid biosynthetic. |
|
R. Katherine (Kate) Hyde, PhD Research focus: Understand the mechanisms that regulate leukemia development; develop treatments for hematological malignancies. |
|
Maneesh Jain, PhD Research focus: Development of genetically engineered antibody fragments for improved radioimmunotherapy for solid tumors; development of serum assays for the early diagnosis of lethal pancreatic cancer. |
|
Keith R. Johnson, PhD Research focus: The role the cell adhesion molecules (cadherins) play in metastasis. |
|
Shantaram S. Joshi, PhD Research focus: Improve therapy for human B lymphocytic malignancies and pediatric cancers by means of translational research involving molecular characterization of progressive/therapy resistant maliganant cells. |
|
Adam R. Karpf, PhD Research focus: Ovarian cancer biology and therapeutics; Cancer epigenetics. |
|
Kusum Kharbanda, PhD Research focus: Alcohol liver injury with emphasis on alcohol's deleterious effect in altering the methionine metabolic pathway and lowering the ratio of the methyl dontor, SAM, to its product, SAH. |
|
So-Youn Kim, PhD Research focus: Oncofertility, cachexia, ovarian cancer. |
|
Zeljka Korade, DVM, PhD Research focus: Cholesterol metabolism in the central nervous system; study of an inborn error of metabolism Smith-Lemli-Opitz syndrome; desmosterolosis; development of neuronal cell lines with defects in different enzymes of cholesterol biosynthesis pathway and their characterization. |
|
Mohan Krishnan, PhD Research focus: Pathophysiology of Tranfusion-associated Necrotizing Enterocolitis (TA-NEC) and Systemic Inflammatory Response Syndrome(SIRS) in premature infants. |
|
Sushil Kumar, PhD Research focus: Tumor microenvironment; Pancreatic pathologies including pancreatic cancer and pancreatitis using multiple murine models, organoid, and 3D cell culture-based technologies. |
|
Marilynn Larson, PhD Research focus: Host and intracellular pathogen interactions, and determining the mechanisms that allow the Tier 1 select agent Francisella tularensis to persist and rapidly replicate within infected macrophages. |
|
Robert Lewis, PhD Research focus: Defining intracellular mechanisms required for the epithelia-mesenchymal transition (EMT) and the formation and maintenance of cancer stem cells. |
|
Brian Lowes, MD, PhD Research focus: Novel education clinical trainees and education program with a goal to develop clinicians and scientists in sub-Saharan Africa. |
|
Xu Luo, PhD Research focus: Molecular mechanisms and signaling pathways in cell death and survival in cancer cells. |
|
Sidharth Mahapara, MD, PhD Research focus: Elucidating pathophysiologic mechanisms triggering aggressive pediatric brain tumors using transcriptomic analyses to hone in on essential signaling pathways and to test synthetic inhibitors of these pathways; Repurposing FDS-approved drugs for treatment of aggressive pediatric brain tumors. |
|
Luis Marky, PhD Research focus: Biophysical chemistry and molecular forces that control the conformational stability and flexibility of nucleic acids, including Okazaki fragments, hairpin loops, intramolecular triplexes, G-quadruplexes, C-quadruplexes, and three- & four-arm DNA junctions and their interaction with drugs. |
|
Grinu Mathew, PhD Research focus: Genetic and epigentic regulation of prostate cancer metastasis. |
|
Benita McVicker, PhD Research focus: Alcohol liver injury and mechanisms. |
|
Karoly Mirnics, MD, PhD Research focus: Animal models of neurodevelopmental and psychiatric disorders; effects of Gene-Environmental-Drug interactions on the developing brain; role of disrupted cholesterol biosynthesis of brain function - all using genetic, molecular, cellular and biochemical tools in our studies, coupled with drug screening and mouse behavioral assessments. |
|
Justin L. Mott, PhD, MD Research focus: Receptor tyrosine kinase and microRNA regulation of apoptosis in liver cancer and bile duct injury. |
|
DJ Murry, PharmD Research focus: Ways to individualize drug therapy using pharmacokinetic and pharmacogenomics information; from in vitro metabolism and transport studies, animal pharmacokinetic studies, to clinical studies evaluating drug therapy in patients. |
|
Prabagaran (Praba) Narayanasamy, PhD Research focus: Drug design, discovery and development (including drug delivery by nanomedicine) for infectious diseases; study of physiology and pathogenesis of bacteria and virus towards drug discovery; design, synthesis and characterization of substrates, inhibitors, intermediates, products and mechanisms for drug discovery and development. |
|
Naava Naslavsky, PhD Research focus: Development of new strategies to treat diseases involving traffic and recycling events related to the control of receptor localization to the plasma membrane that is central to normal cell function, and dysregulation as the underlying cause for diseases as diverse as atherosclerosis, diabetes and cancer. |
|
Wasim (Mohd) Nasser, PhD Research focus: Novel therapeutic strategies for immunosuppressive and tumor-supportive microenvironments of metastatic breast and lung cancers. |
|
Amarnath (Amar) Natarajan, PhD Research focus: Developing novel target and mechanism specific therapeutics. |
|
Caroline Ng, PhD Research focus: Biology and pathogenesis of Plasmodium falciparum, genetic and molecular mechanisms underlying drug resistance. |
|
Michael M. Ouellette, PhD Research focus: Molecular mechanisms that determine the lifespan of human cells, including telomeres and telomerase. Role of the small GTPases K-Ras and Rac1 in the development of pancreatic cancer and its response to conventional therapies. |
|
Scot Ouellette, PhD Research focus: Chlamydial microbiology: bacterial cell division, gene regulation, host-pathogen interactions. |
|
David Oupicky, PhD Research focus: Design of multifunctional nanoparticles and polymers with application in the treatment of metastatic cancer, inflammatory bowel disease and acute kidney injury. |
|
Youri Pavlov, PhD Research focus: Cellular systems of mutagenesis and antimutagenesis. |
|
Palsamy Periyasamy, PhD Research focus: Investigate the epigenetic changes that occur during HIV-1 infection and drug abuse, leading to glial cells (microglia and astrocytes) activation; identify potential therapeutic strategies for HAND treatment. |
|
Armen Petrosyan, MD, PhD Research focus: Mechanism of Golgi alteration in advanced prostate cancer: focus on aberrant glycosylation; role for non-muscle Myosin IIA in alcohol-induced Golgi fragmentation. |
|
Moorthy Ponnusamy, PhD Research focus: Cancer stem cells; metastasis; progression of pancreatic cancer. |
|
Subu Ramanathan, PhD Research focus: Principles that underpin how cells with divergent sizes pack into epithelial tissue and how alterations in cellular packing influence tissue homeostasis. |
|
William Rizzo, MD Research focus: Sjogren-Larsson Syndrome and other inherited metabolic diseases. |
|
Don Ronning, PhD Research focus: Discovery and development of anti-infective and anti-cancer compounds. |
|
Shyamal K. Roy, PhD Research focus: Endocrine regulation of follicular development, growth factors, signal transduction in ovarian cells and biochemistry of granulosa cells. |
|
Micah Schott, PhD Research focus: Cell biology of lipids in metabolic disease. |
|
Polina Shcherbakova, PhD Research focus: Mechanisms controlling genome stability in eukaryotic cells, particularly the functions of DNA polymerases, DNA replication fidelity and the relationship between DNA polymerase defects and cancer. |
|
Jawed Siddiqui, PhD Research focus: Bone metastasis, bone microenvironment, chemokines and cytokines, osteoimmunology, bone-muscle cross-talk, and cancer therapeutics. |
|
Amar Singh, PhD Research focus: Molecular mechanisms inflammatory bowel disease and colon cancer; renal pathobiology. |
|
Rakesh K. Singh, PhD Research focus: Tumor growth and metastasis, angiogenesis, tumor immunology, cytokine biology. |
|
Joyce Solheim, PhD Research focus: Mechanisms regulating the immune response to tumors and infectious pathogens, and development of new immunotherapies. |
|
Paul Sorgen, PhD Research focus: Advancing our understanding of the fundamental mechanisms of gap junction regulation in the heart, with particular interest and expertise in protein-protein interactions mediated by the carboxylterminal domain of connexins. |
|
Kelly Stauch, PhD Research focus: Role of mitrochondrial dysfunction and altered energy metabolism in the context of neurodegerative diseases and aging. |
|
Melissa Teoh-Fitzgerald, PhD Research focus: Role of oxidative tumor microenvironment in regulating the reciprocal tumor-stroma interactions. |
|
Geoffrey M. Thiele, PhD Research focus: Autoimmunity, immune system disorders, immunopathology; infectious diseases/agents; Rheumatoid arthritis, atherosclerosis, breast cancer and the immune system, bone loss and erosion, alcoholic liver disease. |
|
Saraswathi Viswanathan, PhD Research focus: Determine the role of obesity in modulating the pathogenesis of insulin resistance, alcohol-associated liver injury, and pancreatic cancer. |
|
Guangshun (Gus) Wang, PhD Research focus: Develop novel antimicrobials by combining structural biology and database with in vitro and in vivo toxicity and efficacy studies. |
|
Nicholas Woods, PhD Research focus: Systems biology based analysis of cancer signaling pathways. |
|
Ying Yan, PhD
Professor, Department of Radiation Oncology Research focus: Tumorigenesis, cancer progression and metastasis, and development of new anticancer agents. |
|